Utilising structural knowledge in drug design strategies:: Applications using relibase

被引:79
作者
Günther, J
Bergner, A
Hendlich, M
Klebe, G
机构
[1] Univ Marburg, Inst Pharmaceut Chem, D-35032 Marburg, Germany
[2] Cambridge Crystallog Data Ctr, Cambridge CB2 1EZ, England
关键词
structure-based drug design; protein-ligand interaction; 3D database; data mining;
D O I
10.1016/S0022-2836(02)01409-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The concept of structure-based drug design is based upon an in-depth understanding of the principles of molecular recognition. Despite our lack of a thorough comprehension of these principles, the wealth of protein structures available opens up unprecedented possibilities for new insights from the analysis of these data. Unravelling universal rules of molecular recognition is certainly one of the most appealing goals. But our knowledge is enhanced also when studying the specific determinants that characterise single targets or target families only, and the factors governing and discriminating their recognition properties. Here, we illustrate how the structure-based design process can benefit from the consequent incorporation of database query tools. We discuss representative examples to address issues such as protein flexibility, water molecules in binding pockets, and ligand specificity as some of the most critical aspects of drug design. All studies are carried out using our database system Relibase. We also show the application of Relibase in searching for preferred geometrical patterns between interacting molecular fragments. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:621 / 636
页数:16
相关论文
共 64 条
[31]   Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design [J].
Ladbury, JE .
CHEMISTRY & BIOLOGY, 1996, 3 (12) :973-980
[32]   RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS [J].
LAM, PYS ;
JADHAV, PK ;
EYERMANN, CJ ;
HODGE, CN ;
RU, Y ;
BACHELER, LT ;
MEEK, JL ;
OTTO, MJ ;
RAYNER, MM ;
WONG, YN ;
CHANG, CH ;
WEBER, PC ;
JACKSON, DA ;
SHARPE, TR ;
ERICKSONVIITANEN, S .
SCIENCE, 1994, 263 (5145) :380-384
[33]   PDBsum: a Web-based database of summaries and analyses of all PDB structures [J].
Laskowski, RA ;
Hutchinson, EG ;
Michie, AD ;
Wallace, AC ;
Jones, ML ;
Thornton, JM .
TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (12) :488-490
[34]   PDBsum: summaries and analyses of PDB structures [J].
Laskowski, RA .
NUCLEIC ACIDS RESEARCH, 2001, 29 (01) :221-222
[35]   CRYSTAL-STRUCTURES OF ACONITASE WITH ISOCITRATE AND NITROISOCITRATE BOUND [J].
LAUBLE, H ;
KENNEDY, MC ;
BEINERT, H ;
STOUT, CD .
BIOCHEMISTRY, 1992, 31 (10) :2735-2748
[36]   Blockers of human T cell Kv1.3 potassium channels using de novo ligand design and solid-phase parallel combinatorial chemistry [J].
Lew, A ;
Chamberlin, AR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (23) :3267-3272
[37]   New tools and resources for analysing protein structures and their interactions [J].
Luscombe, NM ;
Laskowski, RA ;
Westhead, DR ;
Milburn, D ;
Jones, S ;
Karmirantzou, M ;
Thornton, JM .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :1132-1138
[38]   THE ROLE OF WATER-MOLECULES IN THE STRUCTURE-BASED DESIGN OF (5-HYDROXYNORVALINE)-2-CYCLOSPORINE - SYNTHESIS, BIOLOGICAL-ACTIVITY, AND CRYSTALLOGRAPHIC ANALYSIS WITH CYCLOPHILIN-A [J].
MIKOL, V ;
PAPAGEORGIOU, C ;
BORER, X .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) :3361-3367
[39]   The role of waters in docking strategies with incremental flexibility for carbohydrate derivatives: Heat-labile enterotoxin, a multivalent test case [J].
Minke, WE ;
Diller, DJ ;
Hol, WGJ ;
Verlinde, CLMJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (10) :1778-1788
[40]   Adenylate kinase motions during catalysis: An energetic counterweight balancing substrate binding [J].
Muller, CW ;
Schlauderer, GJ ;
Reinstein, J ;
Schulz, GE .
STRUCTURE, 1996, 4 (02) :147-156